Alisa Nevskaya

Ms. Alisa Nevskaya

Organic Chemistry, Peoples' Friendship University of Russia, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2020 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
Rosa PurgatorioRosa Purgatorio
Rosa Purgatorio
Modesto de CandiaModesto de Candia
Modesto de Candia
MCMarco Catto
Marco Catto
MRMariagrazia Rullo
Mariagrazia Rullo
Leonardo PisaniLeonardo Pisani
Leonardo Pisani
CACosimo D. Altomare
Cosimo D. Altomare

8 September 2023 in Asian Journal of Organic Chemistry
Verified
Journal Article
Closed access
Alisa NevskayaAlisa Nevskaya
Alisa Nevskaya
AZAnna D. Zinoveva
Anna D. Zinoveva
EEErik Van Der Eycken
Erik Van Der Eycken
LVLeonid G. Voskressensky
Leonid G. Voskressensky


12 January 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Alisa NevskayaAlisa Nevskaya
Alisa Nevskaya
LALada V. Anikina
Lada V. Anikina
Rosa PurgatorioRosa Purgatorio
Rosa Purgatorio
MCMarco Catto
Marco Catto
Orazio NicolottiOrazio Nicolotti
Orazio Nicolotti
Cosimo D. AltomareCosimo D. Altomare
Cosimo D. Altomare
Marine alkaloids belonging to the lamellarins family, which incorporate a 5,6-dihydro-1-phenylpyrrolo[2,1-a]isoquinoline (DHPPIQ) moiety, possess various biological activities, spanning from antiviral and antibiotic activities to cytotoxicity against tumor cells and the reversal of multidrug resistance. Expanding a series of previously reported imino adducts of DHPPIQ 2-carbaldehyde, novel aliphatic and aromatic Schiff bases were synthesized and evaluated herein for their cytotoxicity in five diverse tumor cell lines. Most of the newly synthesized compounds were found noncytotoxic in the low micromolar range (<30 μM). Based on a Multi-fingerprint Similarity Search aLgorithm (MuSSeL), mainly conceived for making protein drug target prediction, some DHPPIQ derivatives, especially bis-DHPPIQ Schiff bases linked by a phenylene bridge, were prioritized as potential hits addressing Alzheimer’s disease-related target proteins, such as cholinesterases (ChEs) and monoamine oxidases (MAOs). In agreement with MuSSeL predictions, homobivalent para-phenylene DHPPIQ Schiff base 14 exhibited a noncompetitive/mixed inhibition of human acetylcholinesterase (AChE) with Ki in the low micromolar range (4.69 μM). Interestingly, besides a certain inhibition of MAO A (50% inhibition of the cell population growth (IC50) = 12 μM), the bis-DHPPIQ 14 showed a good inhibitory activity on self-induced β-amyloid (Aβ)1–40 aggregation (IC50 = 13 μM), which resulted 3.5-fold stronger than the respective mono-DHPPIQ Schiff base 9.

1 December 2021 in Tetrahedron Letters
Verified
Journal Article
Closed access
Alisa NevskayaAlisa Nevskaya
Alisa Nevskaya
AMAlmira R. Miftyakhova
Almira R. Miftyakhova
LALada V. Anikina
Lada V. Anikina
TBTatiana N. Borisova
Tatiana N. Borisova
AVAleksey V. Varlamov
Aleksey V. Varlamov
LVLeonid G. Voskressensky
Leonid G. Voskressensky

1 March 2019 in Chemistry of Heterocyclic Compounds
Verified
Journal Article
Closed access
PDF file
Alisa NevskayaAlisa Nevskaya
Alisa Nevskaya
AMAlmira R. Miftyakhova
Almira R. Miftyakhova